Science
Mechanism of Action
Isorhamnetin exerts its beneficial effects through several precise mechanisms. It functions as a potent antioxidant by directly scavenging reactive oxygen species (ROS) and reactive nitrogen species (RNS), including superoxide and hydroxyl radicals, and by upregulating intrinsic antioxidant defense mechanisms via the Nrf2 signaling pathway. Its robust anti-inflammatory properties stem from suppressing NF-κB activation and significantly reducing key pro-inflammatory cytokines such as IL-1β, IL-6, IL-8, and CXCL10, alongside attenuating epidermal growth factor (EGF)-induced COX-2 expression. Isorhamnetin also provides photoprotection by shielding keratinocytes from UVB-induced intracellular ROS, preventing oxidative damage to cellular components, and maintaining mitochondrial integrity. Additionally, it has been shown to support improved skin barrier function through the activation of peroxisome proliferator-activated receptor (PPAR)-α.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 Protected human keratinocytes against UVB-induced cellular damage, including excessive intracellular ROS generation, oxidative damage, and mitochondrial dysfunction, notably without observed cytotoxicity.
- 02 Significantly decreased proliferation and migration of TNF-α stimulated BEAS-2B cells, concurrently reducing pro-inflammatory cytokines (IL-1β, IL-6, IL-8, CXCL10).
- 03 Inhibited EGF-induced neoplastic cell transformation and suppressed anchorage-dependent and -independent growth of A431 human epithelial carcinoma cells without affecting their viability.
- 04 Isorhamnetin glycosides demonstrated over 50% inhibition of nitric oxide (NO) production in RAW 264.7 macrophage cells, indicating potent anti-inflammatory potential.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Isorhamnetin is a hydrophobic flavonoid that presents significant formulation challenges due to its susceptibility to degradation by heat and pH variations, which can compromise its effectiveness. To enhance stability and improve bioavailability, protective encapsulation or specialized coatings are often required, adding complexity and cost to the formulation process. It is soluble in organic solvents such as DMF and DMSO.
Safety
Safety Profile
Toxicological studies on isorhamnetin are currently insufficient to establish a comprehensive safety profile or to warrant review by regulatory bodies like CIR or SCCS. While a concentration of 5 µM demonstrated photoprotective effects in human keratinocytes without cytotoxicity, higher concentrations (specifically 10-20 µM) were observed to induce cytotoxicity in these same cell types. This suggests a potentially narrow therapeutic window for safe topical application on healthy skin, despite higher concentrations (10-40 µM/µmol/L) showing benefits in specific *in vitro* models (e.g., anti-inflammatory in BEAS-2B cells or anti-cancer in carcinoma cells) without reported healthy cell cytotoxicity in those specific contexts. Further rigorous research is essential to determine a definitive safe maximum concentration for broad topical use.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Isorhamnetin demonstrates promising antioxidant, anti-inflammatory, and photoprotective benefits for skin; however, its overall safety profile and a definitive maximum safe topical concentration for general use remain unestablished due to insufficient toxicological data and observed keratinocyte cytotoxicity at specific higher concentrations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources